Taylor & Francis | Oncology Journals | Submit Today

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Oncology

Publish open access with Taylor & Francis

Explore Portfolio

Looking to publish your next article?

Find the perfect home for your research. This portfolio consists of notably indexed, peer-reviewed, fully open access journals and hybrid journals, where you can choose to publish open access; aiming to serve the academic research community, scientific community and practitioner community.

The below journals have various specialties in:

  • Tumor immunology, immunological biomarkers and anticancer therapies with immunotherapies
  • Thermal energy-based disease treatment
  • Antibody research and development
  • Hematological cancers
  • Etiology and treatment for all cancer types
  • All aspects of oncogenesis, tumor progression and therapeutic strategies
  • Molecular basis of cancer

Find out if your institution or country has an open access agreement to publish with us.

Publishing open access increases the visibility and readership of your research, helping you make an impact beyond your field.
Find Out More

OncoImmunology

2020 Impact Factor 8.110
Five-Year Impact Factor 7.959

Oncoimmunology publishes international translational and clinical research into tumor immunology including anticancer therapies and immunotherapies.

Visit Journal Submit

International Journal of Hyperthermia

2020 Impact Factor 3.914
Five-Year Impact Factor 4.285

The International Journal of Hyperthermia publishes peer reviewed research and clinical studies on thermal energy-based disease treatments.

Visit Journal Submit


 

mAbs

2020 Impact Factor 5.857
Five-Year Impact Factor 6.015

mAbs publishes antibody research on topics including targets relevant to cancer and immune-mediated disorders, and antibody therapeutics.

Visit Journal Submit

Leukemia & Lymphoma

2020 Impact Factor 3.280
Five-Year Impact Factor 3.075

Leukemia & Lymphoma publishes research on hematological cancers, covering disease biology, novel agents, chemotherapy, pharmacology/pharmacogenomics, ethics and epidemiology.

Visit Journal Submit


 

Acta Oncologica

2020 Impact Factor 4.089
Five-Year Impact Factor 4.236

Acta Oncologica publishes research into oncology, covering the etiology and treatment for all cancer types as well as experimental and clinical cancer research.

Visit Journal Submit

Molecular & Cellular Oncology

Molecular & Cellular Oncology publishes fundamental, translational and clinical research on all aspects of oncogenesis, tumor progression and therapeutic strategies.

Visit Journal Submit


 

Expert Review of Anticancer Therapy

2020 Impact Factor 4.512
Five-Year Impact Factor 3.665

Provides expert appraisal in cancer care, including tumor management, novel therapies, anticancer agents, chemotherapy, cancer vaccines, and biomarkers.

Visit Journal Submit

Cancer Biology & Therapy

2020 Impact Factor 4.742
Five-Year Impact Factor 4.342

Cancer Biology & Therapy publishes articles on the molecular basis of cancer, including translational diagnostic relevance or therapy, reviews, op-ed pieces and meeting reports.

Visit Journal Submit


 

Nutrition and Cancer

2020 Impact Factor 2.900
Five-Year Impact Factor 3.144

Nutrition and Cancer publishes research on the impact of nutrition on cancer etiology, therapy, and prevention, covering topics like, carcinogenesis, dietetics, and food policies.

Visit Journal Submit

Journal of Chemotherapy

2020 Impact Factor 1.714
Five-Year Impact Factor 1.791

This journal publishes international research on all aspects of antimicrobial and antitumor chemotherapy including anticancer drugs and gene therapy.

Visit Journal Submit


 

Southern African Journal of Gynaecological Oncology

This journal focuses on all aspects of female cancer prevention, detection, diagnosis and treatment.

Visit Journal Submit

Pediatric Hematology and Oncology

2020 Impact Factor 1.969
Five-Year Impact Factor 2.026

The journal publishes pediatric research in blood disorders and malignancies, including pharmacology, stem cells, molecular targeting, immune therapies & transplantation.

Visit Journal Submit

Questions about the publishing process?

Visit our dedicated and ever-expanding site for authors, Author Services, to find out more about how to get published and your publishing options.
Find Out More

SHARE THIS PAGE

F1000Research is an Open Research publishing platform for scientists, scholars and clinicians, supporting data deposition and sharing. Publish all your findings including null results, data notes and more.
Go To F1000Research
Dove Medical Press is part of the Taylor & Francis Group, specializing in the publication of Open Access peer-reviewed journals across the broad spectrum of science, technology and especially medicine.
Go To Dove Press

Latest tweets from @tandfmedicine